1. European Medicines Agency. (2008) Reflection paper on benefit–risk assessment methods in the context of the evaluation of marketing authorisation applications of medicinal products for human use (EMEA/CHMP/15404/2007). Access at http://www.ema.europa.eu/, Special topics, Benefit–risk methodology
2. Benefit–Risk Methodology Project;European Medicines Agency,2009
3. Groupthink: Psychological Studies of Policy Decisions and Fiascoes;Janis,1982
4. Probabilistic information processing systems: design and evaluation;Edwards;IEEE Trans. Syst. Sci. Cybernet.,1968
5. Emerging technologies for making decisions;Edwards,1965